LNTH - Lantheus Holdings, Inc.
96.23
2.160 2.245%
Share volume: 1,130,846
Last Updated: 05-12-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$94.07
2.16
0.02%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-31-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-06-2025 | 02-26-2026 | 05-07-2026 | |
| Assets | |||||||||
| Total Assets | 1.940 B | 2.050 B | 1.980 B | 2.055 B | 2.116 B | 2.276 B | 2.227 B | 2.347 B | |
| Current Assets | 1.231 B | 1.296 B | 1.327 B | 1.424 B | 1.202 B | 925.091 M | 899.964 M | 942.288 M | |
| Inventories | 70.516 M | 70.835 M | 68.025 M | 69.126 M | 62.157 M | 62.040 M | 64.674 M | 61.339 M | |
| Other Current Assets | 24.165 M | 21.998 M | 24.536 M | 67.372 M | 34.093 M | 21.169 M | 21.400 M | 25.214 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 757.018 M | 866.386 M | 912.814 M | 938.533 M | 695.572 M | 382.006 M | 359.121 M | 498.582 M | |
| Total Non-current Assets | 116.423 M | 158.791 M | 39.489 M | 30.375 M | 45.068 M | 46.474 M | 42.213 M | 58.312 M | |
| Property Plant Equipment | 158.158 M | 169.512 M | 176.798 M | 180.783 M | 157.726 M | 164.072 M | 163.686 M | 157.563 M | |
| Other Assets | 550.527 M | 584.404 M | 476.909 M | 450.661 M | 756.535 M | 1.187 B | 1.164 B | 1.247 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.940 B | 2.050 B | 1.980 B | 2.055 B | 2.116 B | 2.276 B | 2.227 B | 2.347 B | |
| Total liabilities | 913.146 M | 869.922 M | 892.329 M | 891.030 M | 949.294 M | 1.157 B | 1.138 B | 1.134 B | |
| Total current liabilities | 263.285 M | 784.079 M | 240.526 M | 248.002 M | 280.132 M | 346.838 M | 333.419 M | 333.166 M | |
| Accounts Payable | 262.417 M | 219.366 M | 239.552 M | 247.255 M | 249.491 M | 317.401 M | 310.213 M | 332.363 M | |
| Other liabilities | 63.543 M | 61.993 M | 63.180 M | 58.190 M | 102.179 M | 187.204 M | 181.121 M | 177.882 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 563.188 M | 613.000 K | 565.279 M | 566.098 M | 566.847 M | 567.937 M | 568.678 M | 569.604 M | |
| Other liabilities | 63.543 M | 61.993 M | 63.180 M | 58.190 M | 102.179 M | 187.204 M | 181.121 M | 177.882 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.027 B | 1.180 B | 1.088 B | 1.164 B | 1.167 B | 1.119 B | 1.090 B | 1.212 B | |
| Common stock | 776.253 M | 798.139 M | 818.681 M | 822.062 M | 845.620 M | 871.911 M | 889.038 M | 893.672 M | |
| Retained earnings | 326.642 M | 457.735 M | 445.945 M | 518.890 M | 597.645 M | 625.416 M | 679.504 M | 797.921 M |